Side effects of anti-angiogenic drugs
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference37 articles.
1. Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies;Gerber;Cancer Res,2005
2. Noncardiac vascular toxicities of vascular endothelial growth factor inhibitors in advanced cancer: a review;Keefe;Oncologist,2011
3. Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results;Rugo;J Clin Oncol,2005
4. A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors;Fox;J Clin Oncol,2010
5. Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis;Houk;Cancer Chemother Pharmacol,2010
Cited by 112 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Angiogenic protein profiling, phytochemical screening and in silico anti-cancer targets validation of stem, leaves, fruit, and seeds of Calotropis procera in human liver and breast cancer cell lines;Environmental Research;2024-09
2. A Concerning Case of Severe Gastritis With Gastrointestinal Protein Loss;Gastroenterology;2024-08
3. Innovating Cancer Treatment Through Cell Cycle, Telomerase, Angiogenesis, and Metastasis;DNA and Cell Biology;2024-07-17
4. Cardiovascular implications of anti-angiogenic therapeutic agents in cancer patients;American Heart Journal Plus: Cardiology Research and Practice;2024-07
5. CDC42 Inhibitors Alter Patterns of Vessel Arborization in Skin and Tumors in vivo;2024-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3